INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2018

IgE sensitization to galactose-α-1,3-galactose was linked to higher atheroma volume and more unstable plaque features, especially in subjects ≤65 years old.

Researchers measured total IgE and specific IgE to galactose-α-1,3-galactose (α-Gal) in 118 subjects undergoing cardiac catheterization with intravascular ultrasound. IgE to α-Gal was detected in 26% of subjects, and atheroma burden was significantly higher in sensitized individuals (P=0.02). In participants ≤65 years of age, the association with atheroma burden was stronger (P<0.001), with plaques displaying less stable features. The association remained significant after adjusting for sex, diabetes mellitus, hypertension, statin use, and total IgE (regression coefficient, 12.2; SE, 5.2; P=0.02), whereas IgE to inhalants and peanut showed no association with coronary artery disease.

Shows an association, not proof of cause and effect.

Study type
Cross-sectional observational study
Who was studied
118 subjects presenting for cardiac catheterization who had intravascular ultrasound
What was measured
Atheroma burden and plaque stability characteristics

THE PAPER

IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics-Brief Report.

Wilson JM, Nguyen AT, Schuyler AJ, Commins SP, Taylor AM, Platts-Mills TAE, McNamara CA. Arterioscler Thromb Vasc Biol, 2018.

PubMed 29903734 ↗DOI 10.1161/atvbaha.118.311222 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.